Difference between revisions of "Gestational trophoblastic neoplasia"
Jump to navigation
Jump to search
m |
m |
||
Line 1: | Line 1: | ||
− | + | {| class="wikitable" style="text-align:center; width:50%;" | |
− | + | !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' | |
− | < | + | |- |
+ | |style="background-color:#F0F0F0"|[[File:Dewdney.jpg|frameless|upright=0.3|center]] | ||
+ | |<big>[[User:Summerdewdney|Summer B. Dewdney, MD]]<br>Chicago, IL</big> | ||
+ | |- | ||
+ | |} | ||
{| class="wikitable" style="float:right; margin-right: 5px;" | {| class="wikitable" style="float:right; margin-right: 5px;" | ||
|- | |- | ||
Line 17: | Line 21: | ||
===Regimen {{#subobject:fcf204|Variant=1}}=== | ===Regimen {{#subobject:fcf204|Variant=1}}=== | ||
{| class="wikitable" style="width: 100%; text-align:center;" | {| class="wikitable" style="width: 100%; text-align:center;" | ||
− | !Study | + | !style="width: 25%"|Study |
− | ![[Levels_of_Evidence#Evidence|Evidence]] | + | !style="width: 25%"|[[Levels_of_Evidence#Evidence|Evidence]] |
− | !Comparator | + | !style="width: 25%"|Comparator |
− | ![[Levels_of_Evidence#Efficacy|Efficacy]] | + | !style="width: 25%"|[[Levels_of_Evidence#Efficacy|Efficacy]] |
|- | |- | ||
|[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068058/ Osborne et al. 2011 (GOG 0174)] | |[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068058/ Osborne et al. 2011 (GOG 0174)] | ||
Line 42: | Line 46: | ||
===Regimen {{#subobject:b3d0ec|Variant=1}}=== | ===Regimen {{#subobject:b3d0ec|Variant=1}}=== | ||
{| class="wikitable" style="width: 100%; text-align:center;" | {| class="wikitable" style="width: 100%; text-align:center;" | ||
− | !Study | + | !style="width: 25%"|Study |
− | ![[Levels_of_Evidence#Evidence|Evidence]] | + | !style="width: 25%"|[[Levels_of_Evidence#Evidence|Evidence]] |
− | !Comparator | + | !style="width: 25%"|Comparator |
− | ![[Levels_of_Evidence#Efficacy|Efficacy]] | + | !style="width: 25%"|[[Levels_of_Evidence#Efficacy|Efficacy]] |
|- | |- | ||
|[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068058/ Osborne et al. 2011 (GOG 0174)] | |[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068058/ Osborne et al. 2011 (GOG 0174)] |
Revision as of 01:32, 11 October 2018
Section editor | |
---|---|
Summer B. Dewdney, MD Chicago, IL |
4 regimens on this page
6 variants on this page
|
Low-risk disease, all lines of therapy
Dactinomycin monotherapy
back to top |
Regimen
Study | Evidence | Comparator | Efficacy |
---|---|---|---|
Osborne et al. 2011 (GOG 0174) | Phase III (E) | Methotrexate | Seems to have superior CR rate |
Chemotherapy
- Dactinomycin (Cosmegen) 1.25 mg/m2 IV push once every 2 weeks
Treatment continued "until the βhCG assay had reached the institutional normal, or until either a rise or plateau in the βhCG level was observed"
References
- GOG 0174: Osborne RJ, Filiaci V, Schink JC, Mannel RS, Alvarez Secord A, Kelley JL, Provencher D, Scott Miller D, Covens AL, Lage JM. Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study. J Clin Oncol. 2011 Mar 1;29(7):825-31. Epub 2011 Jan 24. link to original article link to PMC article contains verified protocol PubMed
Methotrexate monotherapy
back to top |
Regimen
Study | Evidence | Comparator | Efficacy |
---|---|---|---|
Osborne et al. 2011 (GOG 0174) | Phase III (C) | Dactinomycin | Seems to have inferior CR rate |
Chemotherapy
- Methotrexate (MTX) 30 mg/m2 IM once per week
Treatment continued "until the βhCG assay had reached the institutional normal, or until either a rise or plateau in the βhCG level was observed"
References
- GOG 0174: Osborne RJ, Filiaci V, Schink JC, Mannel RS, Alvarez Secord A, Kelley JL, Provencher D, Scott Miller D, Covens AL, Lage JM. Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study. J Clin Oncol. 2011 Mar 1;29(7):825-31. Epub 2011 Jan 24. link to original article link to PMC article contains verified protocol PubMed